RO4876904

DPP-4 inhibitor RO4876904 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO4876904, covering 2016-08-05 to 2016-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes. [Phase 2]